<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36147800</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>The possible association between epidemics of hand-foot-and-mouth disease and responsiveness to immunoglobulin therapy in Kawasaki disease.</ArticleTitle><Pagination><StartPage>968857</StartPage><MedlinePgn>968857</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">968857</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2022.968857</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Enterovirus causing hand-foot-mouth disease (HFMD) has been reported to be associated with the development of Kawasaki disease (KD), whereas the involvement of enterovirus in the clinical course of KD is uncertain. The aim of this study is to investigate the association between the clinical course of KD and HFMD epidemics.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This study included 108 patients who developed KD during HFMD epidemic seasons (July and August) from 2010 to 2014 and who were initially treated with high-dose intravenous immunoglobulin (IVIG). A mean of ≥5.0 HFMD patients reported weekly from each sentinel medical facility was considered to represent a large HFMD epidemic. We compared the clinical characteristics of KD patients in summers of years with and without large HFMD epidemics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Large HFMD epidemics occurred in 2011 and 2013. The number of KD patients in summer was the highest in 2011. The proportion of patients with resistance to the IVIG therapy in summers of years with the large epidemics (14%) was significantly lower than that in summers of other years (31%, <i>P</i> = 0.030), whereas the proportion of patients with coronary artery abnormalities did not differ to a statistically significant extent. The development of KD during large HFMD epidemics was significantly associated with a lower risk of resistance to the IVIG therapy (incidence rate ratio 0.92, <i>P</i> = 0.049).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Patients developing KD during large HFMD epidemic may have good responsiveness to IVIG. It is important to identify microbes from KD patients to predict responsiveness to IVIG therapy.</AbstractText><CopyrightInformation>Copyright © 2022 Shimizu, Hoshina, Kawamura, Tomita, Hidaka, Kojiro, Muneuchi, Kamizono, Yamaguchi, Fujino and Kusuhara.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Occupational and Environmental Health, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoshina</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Occupational and Environmental Health, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawamura</LastName><ForeName>Masaru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Occupational and Environmental Health, Kitakyushu, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, National Hospital Organization Kokura Medical Center, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomita</LastName><ForeName>Yoshie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kitakyushu Municipal Yahata Hospital, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hidaka</LastName><ForeName>Yasufumi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kojiro</LastName><ForeName>Masumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kitakyushu General Hospital, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muneuchi</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Japan Community Health Care Organization Kyushu Hospital, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamizono</LastName><ForeName>Junji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kitakyushu Municipal Yahata Hospital, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamaguchi</LastName><ForeName>Kenichiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Hospital Organization Kokura Medical Center, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujino</LastName><ForeName>Yoshihisa</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Environmental Epidemiology, School of Medicine, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusuhara</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Occupational and Environmental Health, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Kawasaki disease (KD)</Keyword><Keyword MajorTopicYN="N">enterovirus (EV)</Keyword><Keyword MajorTopicYN="N">hand-foot-and-mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">negative correlation</Keyword><Keyword MajorTopicYN="N">responsiveness to immunoglobulin therapy</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>2</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36147800</ArticleId><ArticleId IdType="pmc">PMC9485717</ArticleId><ArticleId IdType="doi">10.3389/fped.2022.968857</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burns JC, Glodé MP. Kawasaki syndrome. Lancet. (2004) 364:533–44. 10.1016/S0140-6736(04)16814-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)16814-1</ArticleId><ArticleId IdType="pubmed">15302199</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T, Nakashima Y, Sakai Y, Nishio H, Motomura Y, Yamasaki S. Kawasaki disease: a matter of innate immunity. Clin Exp Immunol. (2016) 186:134–43. 10.1111/cei.12832</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12832</ArticleId><ArticleId IdType="pmc">PMC5054572</ArticleId><ArticleId IdType="pubmed">27342882</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C, Bayry J, Kone-Paut I, Kaveri SV. Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev. (2010) 9:441–8. 10.1016/j.autrev.2009.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.12.004</ArticleId><ArticleId IdType="pmc">PMC7185630</ArticleId><ArticleId IdType="pubmed">20004744</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns JC, Herzog L, Fabri O, Tremoulet AH, Rodó X, Uehara R, et al. . Seasonality of Kawasaki disease: a global perspective. PLoS ONE. (2013) 8:e74529. 10.1371/journal.pone.0074529</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0074529</ArticleId><ArticleId IdType="pmc">PMC3776809</ArticleId><ArticleId IdType="pubmed">24058585</ArticleId></ArticleIdList></Reference><Reference><Citation>Makino N, Nakamura Y, Yashiro M, Kosami K, Matsubara Y, Ae R, et al. . Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016. Pediatr Int. (2019) 61:397–403. 10.1111/ped.13809</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.13809</ArticleId><ArticleId IdType="pubmed">30786118</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodó X, Curcoll R, Robinson M, Ballester J, Burns JC, Cayan DR, et al. . Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan. Proc Natl Acad Sci USA. (2014) 111:7952–7. 10.1073/pnas.1400380111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1400380111</ArticleId><ArticleId IdType="pmc">PMC4050536</ArticleId><ArticleId IdType="pubmed">24843117</ArticleId></ArticleIdList></Reference><Reference><Citation>Onouchi Y, Suzuki Y, Suzuki H, Terai M, Yasukawa K, Hamada H, et al. . ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease. Pharmacogenomics J. (2013) 13:52–9. 10.1038/tpj.2011.45</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tpj.2011.45</ArticleId><ArticleId IdType="pubmed">21987091</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu C, Eleftherohorinou H, Wright VJ, Kim J, Alphonse MP, Perry JC, et al. . Genetic variation in the SLC8A1 calcium signaling pathway is associated with susceptibility to Kawasaki Disease and coronary artery abnormalities. Circ Cardiovasc Genet. (2016) 9:559–68. 10.1161/CIRCGENETICS.116.001533</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGENETICS.116.001533</ArticleId><ArticleId IdType="pubmed">27879314</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu D, Hoshina T, Kawamura M, Tomita Y, Hidaka Y, Kojiro M, et al. . Seasonality in clinical courses of Kawasaki disease. Arch Dis Child. (2019) 104:694–6. 10.1136/archdischild-2018-315267</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2018-315267</ArticleId><ArticleId IdType="pubmed">30413486</ArticleId></ArticleIdList></Reference><Reference><Citation>The Infectious Disease Occurrence Trend (fixed point report) (homepage on the Internet) . City of Kitakyushu. Available online at: https://kitakyushu.j-server.com/LUCKKYUSHU/ns/tl.cgi/https://www.city.kitakyushu.lg.jp/ho-huku/18300149.html?SLANG=ja&amp;TLANG=en&amp;XMODE=0&amp;XPARAM=pageIdSearchtxt,&amp;XCHARSET=UTF-8&amp;XPORG=,&amp;XJSID=0 (accessed May 12, 2022).</Citation></Reference><Reference><Citation>Chang LY, Chang IS, Lu CY, Chiang BL, Lee CY, Chen PJ, et al. . Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Pediatrics. (2004) 114:e678–682. 10.1542/peds.2004-0726</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2004-0726</ArticleId><ArticleId IdType="pubmed">15574600</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lu CY, Shao PL, Lee PI, Lin MT, Fan TY, et al. . Viral infections associated with Kawasaki disease. J Formos Med Assoc. (2014) 113:148–54. 10.1016/j.jfma.2013.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2013.12.008</ArticleId><ArticleId IdType="pmc">PMC7125523</ArticleId><ArticleId IdType="pubmed">24495555</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KP, Cheng-Chung Wei J, Huang SH, Chien KJ, Lin CC, et al. . Enterovirus infection and subsequent risk of Kawasaki Disease: a population-based cohort study. Pediatr Infect Dis J. (2018) 37:310–5. 10.1097/INF.0000000000001748</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001748</ArticleId><ArticleId IdType="pubmed">28834956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. . Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int. (2005) 47:232–4. 10.1111/j.1442-200x.2005.02033.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-200x.2005.02033.x</ArticleId><ArticleId IdType="pubmed">15771703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. . Prediction of intravenous immunoglobulinunresponsiveness in patients with Kawasaki disease. Circulation. (2006) 113:2606–12. 10.1161/CIRCULATIONAHA.105.592865</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.592865</ArticleId><ArticleId IdType="pubmed">16735679</ArticleId></ArticleIdList></Reference><Reference><Citation>JCS Joint Working Group . Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J. (2014) 78:2521–62. 10.1253/circj.CJ-66-0096</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-66-0096</ArticleId><ArticleId IdType="pubmed">25241888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y. Epidemiology, treatments, and cardiac complications in patients with Kawasaki Disease: The nationwide survey in Japan, 2017-2018. J Pediatr. (2020) 225:23–29. e2. 10.1016/j.jpeds.2020.05.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.05.034</ArticleId><ArticleId IdType="pubmed">32454114</ArticleId></ArticleIdList></Reference><Reference><Citation>Surveillance data from Kitakyushu Institute of Health and Environmental Sciences . City of Kitakyushu (in Japanese). Available online at: https://www.city.kitakyushu.lg.jp/shisetsu/menu06_0140.html (accessed January 23, 2022).</Citation></Reference><Reference><Citation>Abzug MJ, Keyserling HL, Lee ML, Levin MJ, Rotbart HA. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis. (1995) 20:1201–6. 10.1093/clinids/20.5.1201</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.5.1201</ArticleId><ArticleId IdType="pubmed">7620000</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Moore DD, Nix WA, Oberste MS, Weldon WC. Neutralization of Enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products. J Clin Virol. (2015) 69:172–5. 10.1016/j.jcv.2015.06.086</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.06.086</ArticleId><ArticleId IdType="pmc">PMC6512324</ArticleId><ArticleId IdType="pubmed">26209401</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Qi J. Prevalence and management of severe hand, foot, and mouth disease in Xiangyang, China, from 2008 to 2013. Front Pediatr. (2020) 8:323. 10.3389/fped.2020.00323</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.00323</ArticleId><ArticleId IdType="pmc">PMC7366859</ArticleId><ArticleId IdType="pubmed">32754560</ArticleId></ArticleIdList></Reference><Reference><Citation>Galama JM, Gielen M, Weemaes CM. Enterovirus antibody titers after IVIG replacement in agammaglobulinemic children. Clin Microbiol Infect. (2000) 6:630–2. 10.1046/j.1469-0691.2000.00173.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1469-0691.2000.00173.x</ArticleId><ArticleId IdType="pubmed">11168072</ArticleId></ArticleIdList></Reference><Reference><Citation>Cellier C, Foray S, Hermine O. Regional enteritis associated with enterovirus in a patient with X-linked agammaglobulinemia. N Engl J Med. (2000) 342:1611–2. 10.1056/NEJM200005253422113</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200005253422113</ArticleId><ArticleId IdType="pubmed">10841685</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, et al. . Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol. (2012) 22:216–21. 10.2188/jea.JE20110126</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20110126</ArticleId><ArticleId IdType="pmc">PMC3798622</ArticleId><ArticleId IdType="pubmed">22447211</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim GB, Park S, Kwon BS, Han JW, Park YW, Hong YM. Evaluation of the temporal association between Kawasaki Disease and viral infections in South Korea. Korean Circ J. (2014) 44:250–4. 10.4070/kcj.2014.44.4.250</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2014.44.4.250</ArticleId><ArticleId IdType="pmc">PMC4117846</ArticleId><ArticleId IdType="pubmed">25089137</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai CM, Yu HR, Tang KS, Huang YH, Kuo HC. C-reactive protein to albumin ratio for predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease. Front Pediatr. (2020) 8:607631. 10.3389/fped.2020.607631</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.607631</ArticleId><ArticleId IdType="pmc">PMC7723900</ArticleId><ArticleId IdType="pubmed">33324592</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortuna-Reyna B, Bainto EV, Ulloa-Gutierrez R, Garrido-García LM, Estripeaut D, Del Águila O, et al. . Use of adjunctive therapy in acute Kawasaki disease in Latin America. Front Pediatr. (2020) 8:442. 10.3389/fped.2020.00442</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.00442</ArticleId><ArticleId IdType="pmc">PMC7646534</ArticleId><ArticleId IdType="pubmed">33194876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent L, McPherson M, Higgins N. A positive association between cryptosporidiosis notifications and ambient temperature, Victoria, Australia, 2001-2009. J Water Health. (2015) 13:1039–47. 10.2166/wh.2015.130</Citation><ArticleIdList><ArticleId IdType="doi">10.2166/wh.2015.130</ArticleId><ArticleId IdType="pubmed">26608765</ArticleId></ArticleIdList></Reference><Reference><Citation>Jusot JF, Neill DR, Waters EM, Bangert M, Collins M, Bricio Moreno L, et al. . Airborne dust and high temperatures are risk factors for invasive bacterial disease. J Allergy Clin Immunol. (2017) 139:977–86. 10.1016/j.jaci.2016.04.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.04.062</ArticleId><ArticleId IdType="pmc">PMC5338876</ArticleId><ArticleId IdType="pubmed">27523432</ArticleId></ArticleIdList></Reference><Reference><Citation>Claus H, Vogel U, Swiderek H, Frosch M, Schoen C. Microarray analyses of meningococcal genome composition and gene regulation: a review of the recent literature. FEMS Microbiol Rev. (2007) 31:43–51. 10.1111/j.1574-6976.2006.00047.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2006.00047.x</ArticleId><ArticleId IdType="pubmed">17096662</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>